Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric antigen receptors targeting CD70

Chimeric antigen receptors targeting CD70

US Patent 12152081 · Granted Nov 26, 2024

Estimated economic value: $909,961,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treatment using anti-CD19 rituximab-resistant chimeric antigen recepto2025
Protease-activating CD45-gate CAR2025
Protease-activating CD45-gate CAR2025
Protease-activating CD45-gate CAR2025
Chimeric antigen receptors targeting FLT32025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Peptide derived from PEP27 peptide and uses thereof2024
Methods of manufacturing allogeneic CAR T cells2024
Inducible chimeric cytokine receptors2024
Modified caspase-9 polypeptides and methods of use thereof2024